The cGMP-PKG system is suggested as a disease driver of retinal degeneration, not the least in the rd1 model, where the inhibition of PKG has been repeatedly shown to counteract the degeneration, including in studies based on retinal explants [4,9]. Here, PRKG1 is linked to retinal degeneration.